GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- Focusing on Advanced Manufacturing, Phase 1 of the 139th Canton Fair is set to…
GUANGZHOU, China, April 14, 2026 /PRNewswire/ -- The 139th China Import and Export Fair (Canton Fair) will be held in Guangzhou…
SINGAPORE, April 14, 2026 /PRNewswire/ -- The Responsible Fintech Institute (RFI) has appointed Distinguished Professor Patrick H. M. Loh and…
PANAMA CITY, April 14, 2026 /PRNewswire/ -- HTX Research, the dedicated research arm of HTX Group, has released a new report…
With the biggest meal allowance reform in decades now in effect, EnKash's Tax Benefit Multi-Wallet Card gives Indian employers a…
PHILADELPHIA, April 13, 2026 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration on behalf of the…
Bitmine now owns more than 4% of the total ETH coin supply of 120.7 millionBitmine is 81% of the way…
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…
Company announcement no. 10 - 2614 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG…
April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s…